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	 In	this	work,	the	acidic	degradation	product	of	sitagliptin	phosphate	monohydrate	(STG)	was
synthesized,	 separated	 and	 its	 structure	 was	 elucidated.	 Additionally,	 two	 reversed‐phase
liquid	chromatographic	(RP‐LC)	methods	have	been	developed	for	the	determination	of	STG.
The	first	method	comprised	the	determination	of	STG	in	binary	mixture	with	sitagliptin	acid
degradation	product	 (SDP)	 in	 laboratory	 prepared	mixtures,	 in	 plasma	and	 in	dosage	 form.
This	 method	 was	 based	 on	 isocratic	 elution	 using	 a	 mobile	 phase	 consisting	 of	 potassium
dihydrogen	phosphate	buffer	(pH	=4.6)	‐	acetonitrile	(30:70,	v:v)	with	fluorometric	detection.
The	fluorometric	detector	was	operated	at	267	nm	for	excitation	and	575	nm	for	emission.	In
the	 second	 method,	 the	 simultaneous	 determination	 of	 STG	 and	 metformin	 (MET)	 in	 the
presence	of	SDP	has	been	developed.	In	this	method,	the	ternary	mixture	of	STG,	MET	and	SDP
was	separated	using	a	mobile	phase	consisting	of	potassium	dihydrogen	phosphate	buffer	(pH
=	4.6)	‐	acetonitrile	(15:85,	v:v)	with	UV	detection	at	220	nm.	Chromatographic	separation	in
the	 two	methods	was	 achieved	on	a	 Symmetry®	Waters	C18	 column	 (150	mm	×	 4.6	mm,	5
μm).	The	optimized	methods	were	validated	and	proved	to	be	specific,	robust	and	accurate	for
the	quality	control	of	the	cited	drugs	in	pharmaceutical	preparations.	
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1.	Introduction	
	
Sitagliptin	 (STG),	 [(2R)‐1‐(2,4,5‐trifluorophenyl)‐4‐oxo‐4‐
[3‐(trifluoromethyl)‐5,6‐dihydro	 [1,2,4]triazolo	 [4,3‐a]pyrazin‐
7(8H)‐yl]	butan‐2‐amine]	(Figure	1a),	is	an	hypoglycemic	drug	
that	 belongs	 to	 dipeptidyl‐peptidase‐4	 inhibitor	 class	 which	
stimulates	 glucose‐dependent	 insulin	 release	 [1‐3].	Metformin	
(MET),	N,N‐dimethylimidodicarbonimidic	diamide	(Figure	1b),	
is	 a	 biguanide	 drug	 that	 stimulates	 glycolysis	 in	 peripheral	
tissues	[4].	Recently,	the	combination	of	the	two	drugs	has	been	
recommended	in	the	treatment	of	diabetes	mellitus	to	improve	
glycemic	control	[5].	
A	few	methods	have	been	described	for	the	determination	
of	 STG	 in	 pharmaceutical	 preparations	 including	 spectro‐
photometry	 [1,6],	 HPLC	 [2,3,7]	 and	 fluorometry	 [8].	 Besides,	
some	methods	have	been	reported	for	determination	of	MET	in	
pharmaceutical	 preparations	 including	 LC/MS/MS	 [4]	 and	
HPLC	[9‐11].	
In	a	previous	work	by	the	same	authors	of	the	present	work	
[7],	 the	 determination	 of	 STG	was	 carried	 out	 alone	 and	was	
also	 simultaneously	 determined	with	MET	 in	 the	 presence	 of	
STG	 alkaline	 degradation	 product	 (SDP).	 However,	 the	 acid	
degradation	of	 STG	could	not	be	 separated.	 So,	 the	aim	of	 the	
present	work	 presents	was	 to	 synthesize,	 separate	 and	 study	
the	 acidic	 degradation	 product	 of	 STG	 and	 to	 develop	 LC	
methods	for	the	determination	of	STG	either	in	binary	mixture	
with	its	acidic	degradation	product	(SDP)	or	in	ternary	mixture	
with	 MET	 and	 SDP.	 In	 the	 first	 method	 (LC‐fluoro),	 STG	 and	
SDP	was	determined	applying	fluorometric	detection	based	on	
the	native	fluorescence	of	the	drug	and	the	acidic	degradation	
product.	 Fluorometric	 detection	 was	 chosen	 for	 its	 better	
selectivity	 than	 UV	 detection.	 In	 the	 second	method	 (LC‐UV),	
UV	detection	was	applied	for	the	determination	of	the	ternary	
mixture	due	to	the	lack	of	native	fluorescence	for	MET.	SDP	was	
prepared,	 separated	 and	 its	 structure	 was	 elucidated	 by	
different	spectroscopic	techniques	and	proved	to	be;	3‐amino‐
4‐(2,4,5‐trifluorophenyl)	butanoic	acid,	(Figure	1c).		
	
	
(a)	
	
(b)	
	
	
(c)	
	
Figure	1.	Chemical	structures	of	sitagliptin	(a),	metformin	(b)	and	
sitagliptin	acidic	degradation	product	(c).	
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2.	Experimental	
	
2.1.	Instrumentation	
	
The	HPLC	system	consisted	of	a	Shimadzu	LC‐20	AT	Liquid	
Chromatograph	 (Japan)	 using	 a	 Symmetry® Waters	 C18	
column	 (150	mm	x	4.6	mm,	5	µm)	 (Ireland).	 The	 system	was	
equipped	 with	 a	 flourometric	 detector	 (RF‐551,	 Japan),	 UV‐
visible	 detector	 (SPD‐20A,	 Japan)	 and	 an	 auto	 sampler	 (SIL‐
20A,	 Shimadzu,	 Japan).	 An	 Elma	 S100	 ultrasonic	 processor	
model	KBK	4200	(Germany)	was	used.		
	
2.2.	Reagents	and	reference	samples	
	
Pharmaceutical	 grade	 STG,	 certified	 to	 contain	 99.80%,	
Januvia®	 tablets	 nominally	 containing	 128.5	 mg	 of	 STG	 per	
tablet	 (Batch	 no.	 S0273)	 and	 Janumet®	 tablets	 nominally	
containing	 64.25	 mg	 of	 STG	 and	 1000	 mg	 of	 MET	 per	 tablet	
(Batch	no.	0426570)	were	all	 supplied	 from	Merck	Sharp	and	
Dohme	 Co.	 (Cairo,	 Egypt).	 Inactive	 ingredients	 of	 Januvia®	
tablets	 include	 microcrystalline	 cellulose	 (E460),	 calcium	
hydrogen	 phosphate,	 anhydrous	 (E341),	 croscarmellose	
sodium	 (E468),	 magnesium	 stearate	 (E470b)	 and	 sodium	
stearyl	 fumarate,	 polyvinyl	 alcohol,	 macrogol	 3350,	 talc	
(E553b),	 titanium	 dioxide	 (E171),	 red	 iron	 oxide	 (E172)	 and	
yellow	 iron	 oxide	 (E172).	Whereas	 those	 of	 Janumet®	 tablets	
include	 microcrystalline	 cellulose	 (E460),	 povidone	 K29/32	
(E1201),	 sodium	 lauril	 sulfate,	 sodium	 stearyl	 fumarate,	
polyvinyl	 alcohol,	 macrogol	 3350,	 talc	 (E553b),	 titanium	
dioxide	 (E171),	 iron	 oxide	 red	 (E172)	 and	 iron	 oxide	 black	
(E172).	Pharmaceutical	grade	MET,	certified	to	contain	99.79%	
was	kindly	supplied	by	Chemical	Industries	Development	(Cid)	
Co.	 (Giza,	 Egypt).	HPLC	 grade	 acetonitrile	 and	methanol	were	
purchased	 from	 Fisher	 Scientific	 (Loughborough,	
Leicestershire,	 UK).	 Potassium	 dihydrogen	 phosphate	 and	
orthophosphric	 acid	 (85%)	 were	 purchased	 from	 VWR	
Chemicals	(Pool,	England).	Bi‐distilled	water	was	produced	in‐
house	 (Aquatron	 Water	 Still,	 A4000D,	 UK).	 Membrane	 filters	
0.45	 µm	 from	 Teknokroma	 (Barcelona,	 Spain)	 were	 used.	 All	
other	 chemicals	 and	 reagents	 used	 were	 of	 analytical	 grade	
unless	 indicated	 otherwise.	 Standard	 stock	 solutions	 of	 each	
drug	 (1	mg/mL)	 were	 prepared	 by	 dissolving	 100	mg	 of	 the	
drug	 in	methanol	 and	 completing	 the	 volume	 to	 100	mL	 in	 a	
volumetric	 flask	 and	 then	 the	 required	 concentrations	 were	
prepared	by	serial	dilutions.		
	
2.3.	Plasma	sample	preparation	
	
The	 spiked	 plasma	 samples	 were	 extracted	 after	
precipitation	of	proteins	using	100	μL	of	perchloric	acid	(35%,	
w:w).	 Then,	 the	mixture	was	 vortex‐mixed	 and	 centrifuged	 (2	
and	 3	min,	 respectively).	 The	 supernatant	 was	 separated	 and	
transferred	 to	 another	 tube	 and	 a	 25	μL	 volume	was	 injected	
into	the	chromatograph.		
	
2.4.	Preparation	of	the	acidic	degradation	product	
	
An	amount	of	1	g	of	STG	bulk	powder	was	dissolved	in	250	
mL	 of	 6	 N	 aqueous	 hydrochloric	 acid	 then	 the	 solution	 was	
heated	 for	 8	 h	 on	 a	 boiling	 water	 bath,	 then	 cooled	 and	
neutralized	 by	 6	 N	 aqueous	 sodium	 hydroxide.	 The	 formed	
precipitate	 was	 filtered,	 washed	 several	 times	 and	 dried.	
Complete	degradation	was	confirmed	using	TLC	plates	and	 its	
structure	 was	 then	 elucidated	 by	 different	 spectroscopic	
techniques.	
	
2.5.	Chromatographic	conditions	
	
	
	
	
2.5.1.	LC‐fluoro	method	
	
Chromatographic	separation	was	achieved	on	a	Symmetry®	
Waters	 C18	 column	 (150	 mm	 ×	 4.6	 mm,	 5	 μm)	 applying	 an	
isocratic	 elution	 based	 on	 potassium	 dihydrogen	 phosphate	
buffer	 (pH	=	4.6)	 ‐	 acetonitrile	 (30:70,	v:v)	as	a	mobile	phase.	
The	 fluorometric	 detector	 was	 operated	 at	 267	 nm	 for	
excitation	 and	 575	 nm	 for	 emission.	 The	 buffer	 solution	 was	
filtered	through	0.45	µm	membrane	filter	and	degassed	for	30	
min	in	an	ultrasonic	bath	prior	to	its	use.	The	mobile	phase	was	
pumped	 through	 the	 column	 at	 a	 flow	 rate	 of	 1	 mL/min.	
Analyses	 were	 performed	 at	 ambient	 temperature	 and	 the	
injection	volume	was	25	µL.	
	
2.5.2.	LC‐UV	method	
	
Chromatographic	separation	was	achieved	on	a	Symmetry®	
Waters	 C18	 column	 (150	 mm	 ×	 4.6	 mm,	 5	 μm)	 applying	 an	
isocratic	 elution	 based	 on	 potassium	 dihydrogen	 phosphate	
buffer	 (pH	=	4.6)	 ‐	 acetonitrile	 (15:85,	v:v)	as	a	mobile	phase.	
The	UV	detector	was	operated	at	220	nm.	The	buffer	solution	
was	filtered	through	0.45µm	membrane	filter	and	degassed	for	
30	min	in	an	ultrasonic	bath	prior	to	its	use.	The	mobile	phase	
was	pumped	 through	 the	 column	at	 a	 flow	 rate	 of	 1	mL/min.	
Analyses	 were	 performed	 at	 ambient	 temperature	 and	 the	
injection	volume	was	25	µL.	
	
2.6.	Sample	preparation	
	
Twenty	 tablets	 of	 Januvia®	 and	 Janumet®	were	 separately	
weighed.	An	accurately	weighed	amount	of	the	finely	powdered	
Januvia®	tablets	equivalent	to	100	mg	of	STG	and	a	quantity	of	
the	powdered	 Janumet®	 tablets	 equivalent	 to	 (6.425	mg)	 STG	
and	 (100	mg)	MET	were	 separately	made	up	 to	100	mL	with	
methanol	and	sonicated	to	dissolve.	The	solutions	were	filtered	
followed	by	serial	dilutions	to	 the	required	concentrations	for	
each	experiment.	
	
2.7.	Procedure	
	
2.7.1.	Linearity	and	repeatability	
	
2.7.1.1.	LC‐fluoro	method	
	
Accurately	 measured	 aliquots	 of	 STG	 stock	 solution	
equivalent	 to	50‐2000	µg	were	 transferred	 into	a	 series	of	10	
mL	 volumetric	 flasks	 and	 then	 completed	 to	 volume	 with	
methanol.	A	volume	of	25	µL	of	each	solution	was	injected	into	
the	chromatograph.	The	conditions	including	the	mobile	phase	
at	 a	 flow	 rate	1	mL/min,	 fluorometric	 detection	 (λex:	 267	nm,	
λem:	575	nm)	and	run	time	program	for	10	min	were	adjusted.	A	
calibration	curve	was	obtained	by	plotting	area	under	the	peak	
(AUP)	 against	 concentration	 (C).	 The	 repeatability	 of	 the	
method	was	assessed	by	analyzing	a	mixture	containing	30	and	
100	µg/mL	of	SDP	and	STG,	respectively	(n	=	6).	The	precision	
(%R.S.D.)	 values	 of	 peak	 areas	 and	 retention	 times	 were	
calculated,	Table	1.	
	
2.7.1.1.1.	LC‐fluoro	method	in	plasma	
	
Accurately	measured	aliquots	of	plasma	samples	equivalent	
to	 0.25‐8.00	 µg	 STG	 were	 prepared	 after	 its	 extraction	 as	
mentioned	 under	 Section	 2.3	with	 the	 same	 conditions	 under	
Section	 2.7.1.1.	 A	 calibration	 curve	 was	 obtained	 by	 plotting	
area	 under	 the	 peak	 (AUP)	 against	 concentration	 (C).	 The	
repeatability	 of	 the	 method	 was	 assessed	 by	 analyzing	 a	
mixture	 containing	 1.5	 and	 5.0	 µg/mL	 of	 SDP	 and	 STG,	
respectively	 (n	 =	 6).	 The	 precision	 (%R.S.D.)	 was	 calculated,	
Table	1.	
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Table	1.	System	suitability	tests	for	LC‐fluoro	method	for	the	determination	of	sitagliptin	in	binary	mixture	with	its	acidic	degradation	product.	
Item	*	 In	laboratory	mix	 	 In	plasma	 	
STG	 SDP STG SDP
N	 860	 1024 784	 2578
R	 6.29	 6.29 7.6 7.6
T	 1.14	 1.19 1.02 1.05
%R.S.D.	of	6	injections	 	 	
Peak	area	 0.38	 0.43	 0.48	 0.36	
Retention	time	 0.27	 0.44	 0.57	 0.22	
*	N	(number	of	theoretical	plates),	R	(peak	resolution	factor),	T	(tailing	of	chromatographic	peak),	and	repeatability	as	%R.S.D.	of	peak	area	for	six	injections	and	
reproducibility	of	retention	as	%R.S.D.	of	retention	time.	
	
	
Table	 2.	 System	 suitability	 tests	 for	 LC‐UV	 method	 for	 the	 simultaneous	 determination	 of	 sitagliptin	 and	 metformin	 in	 the	 presence	 of	 sitagliptin	 acidic	
degradation	product.	
Item	*	 STG	degradation	product	 STG	 MET	
N	 1022 3136	 1733
R	 6.5	 2.1	 2.1
T	 1.09 1.01	 1.05	
%R.S.D.	of	6	injections	 	 	 	
Peak	area	 0.46 0.59	 0.47
Retention	time	 0.66 0.22	 0.28
*	N	(number	of	theoretical	plates),	R	(peak	resolution	factor),	T	(tailing	of	chromatographic	peak),	and	repeatability	as	%R.S.D.	of	peak	area	for	six	injections	and	
reproducibility	of	retention	as	%R.S.D.	of	retention	time.	
	
	
2.7.1.2.	LC‐UV	method	
	
Accurately	measured	aliquots	of	stock	solutions	equivalent	
to	 50‐1600	 µg	 STG	 and	 250‐8000	 µg	 MET	 were	 separately	
transferred	into	two	series	of	10	mL	volumetric	flasks	and	then	
completed	to	volume	with	methanol.	A	volume	of	25	µL	of	each	
solution	was	 injected	 into	 the	 chromatograph.	The	 conditions	
including	the	mobile	phase	at	a	 flow	rate	1	mL/min,	detection	
at	220	nm	and	run	time	program	for	10	min	were	adjusted.	A	
calibration	curve	for	each	compound	was	obtained	by	plotting	
area	under	the	peak	(AUP)	against	concentration	(C).	
The	repeatability	of	the	method	was	assessed	by	analyzing	
a	mixture	 containing	 25.7,	 400.0	 and	 7.7	 µg/mL	 of	 STG,	MET	
and	SDP,	respectively	 (n	=	6).	This	mixture	was	considered	as	
the	working	standard	solution.	The	precision	(%R.S.D.)	values	
of	 peak	 areas	 and	 retention	 times	 were	 calculated	 for	 each	
compound,	Table	2.	
	
2.7.2.	Assay	of	laboratory	prepared	mixtures,	plasma	and	
Januvia®	tablets	
	
The	 procedure	 mentioned	 under	 Section	 2.7.1.1	 was	
repeated	using	concentrations	equivalent	to	10‐185	µg/mL	STG	
and	3‐55	µg/mL	SDP	(10%	to	30%	of	STG,	w:w)	and	equivalent	
to	1.0‐7.5	µg/mL	STG	and	0.3‐2.0	µg/mL	SDP	(10%	to	30%	of	
STG,	w:w).	For	the	determination	of	STG	in	Januvia®	tablets,	the	
sample	solution	prepared	under	Section	2.6	was	serially	diluted	
and	then	injected	in	triplicates.	The	concentrations	of	STG	were	
calculated	using	calibration	equation.		
	
2.7.3.	Assay	of	laboratory	prepared	mixtures	and	Janumet®	
tablets		
	
The	 procedure	 mentioned	 under	 Section	 2.7.1.2	 was	
repeated	 for	 the	 determination	 of	 laboratory	 prepared	
mixtures	 equivalent	 to	 10‐45	 µg/mL	 STG,	 155.6‐700.4	 µg/mL	
MET	and	3.0‐13.5	µg/mL	SDP	 (10%	to	30%	of	 STG,	w:w).	For	
the	determination	of	 the	examined	drugs	 in	 Janumet®	 tablets,	
the	 sample	 solution	 prepared	 under	 Section	 2.6	 was	 serially	
diluted	 to	 prepare	 solutions	 equivalent	 to	 10‐45,	 155.6‐700.4	
µg/mL	 of	 STG	 and	 MET,	 respectively;	 and	 then	 injected	 in	
triplicates.	 The	 concentrations	 of	 the	 examined	 drugs	 were	
calculated	using	calibration	equations.	
	
3.	Results	and	discussion	
	
SDP	was	prepared	after	acidic	hydrolysis	of	the	amide	bond	
of	 the	 intact	drug.	Complete	degradation	was	confirmed	using	
TLC	 plates.	 Structure	 elucidation	 of	 the	 obtained	 secondary	
amine	 was	 confirmed	 using	 infra‐red,	 mass	 and	 1H	 NMR	
spectroscopic	 techniques	 and	 proved	 to	 be:	 3‐amino‐4‐(2,4,5‐
trifluorophenyl)	butanoic	acid.	It	is	worth	noting	that	the	other	
hydrolysis	 product	 which	 is:	 3‐(trifluoromethyl)‐5,6,7,8‐tetra	
hydro‐[1,2,4]triazolo[4,3‐a]pyrazine	 could	 not	 be	 separated	
from	the	reaction	medium	with	the	acid	but	it	was	studied	in	a	
previous	 work	 by	 the	 same	 authors	 of	 this	 work	 [7].	 The	 IR	
spectrum	of	SDP	showed	the	shift	of	the	characteristic	peak	of	
the	 carbonyl	 group	 of	 the	 amide	 bond	 at	 1639	 to	 1697	 cm‐1	
which	 is	 the	 characteristic	 peak	 of	 the	 carbonyl	 group	 of	 the	
carboxylic	 acid	 in	 addition	 to	 the	 appearance	 of	 the	
characteristic	broad	peak	of	the	OH	of	the	carboxylic	group.	The	
characteristic	forked	band	of	the	amino	group	appears	at	about	
3100	 cm‐1	 due	 to	 the	 effect	 of	 hydrogen	 bonding	 with	 the	
neighboring	 fluoride	 atom,	 which	 is	 a	 strong	 hydrogen	 bond	
acceptor.	 Besides,	mass	 spectroscopy	 confirmed	 the	 complete	
hydrolysis	 of	 STG	 showing	 the	 molecular	 weight	 of	 the	
obtained	 SDP	 at	 233	 m/z.	 Finally,	 1H	 NMR	 showed	 the	
appearance	 of	 the	 H	 at	 12.4	 ppm	 which	 confirmed	 the	 acid	
product	 and	 also	 showed	 the	 absence	 of	 the	 heterocyclic	
hydrogens	which	ensure	the	degradation.		
	
3.1.	Methods	development		
	
3.1.1.	LC‐fluoro	method	
	
Various	 reversed‐phase	 columns,	 isocratic	 mobile	 phase	
systems	and	different	pH	values	of	the	buffer	were	attempted.	
Isocratic	 elution	 based	 on	 potassium	 dihydrogen	 phosphate	
buffer	(pH	=	4.6)	‐	acetonitrile	(30:70,	v:v)	was	applied	as	STG	
and	SDP	were	eluted	in	a	reasonable	time	and	good	peak	shape	
with	 this	 mobile	 phase	 at	 a	 flow	 rate	 1	 mL/min.	 The	
fluorometric	 detector	 was	 operated	 at	 267	 nm	 for	 excitation	
and	575	nm	 for	 emission	where	high	detector	 sensitivity	was	
achieved	 at	 these	 wavelengths.	 The	 retention	 times	 were	 3.9	
and	6.1	min	for	SDP	and	STG,	respectively	as	shown	in	Figure	2	
and	the	retention	times	were	3.8	and	6.3	min	for	SDP	and	STG,	
respectively	in	plasma	as	shown	in	Figures	3	and	4.	
	
3.1.2.	LC‐UV	method	
	
During	 the	 optimization	 cycle,	 several	 chromatographic	
conditions	 were	 attempted	 using	 Symmetry® Waters	 C18	
column	(150	mm	x	4.6	mm,	5	µm).	The	C18	column	was	chosen	
for	its	availability	in	most	quality	control	laboratories.	Various	
mobile	 phase	 compositions	 containing	 different	 ratios	 of	
organic	and	aqueous	phases	were	tried	in	an	isocratic	mode.	
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Table	3.	Results	obtained	by	LC‐flouro	method	for	the	determination	of	sitagliptin	in	binary	mixture	with	its	acidic	degradation	product.	
Item	*	 STG STG	in	plasma	
Retention	time	 6.1	 6.3
Excitation	wavelength	of	detection		 267	nm	 267	nm	
Emission	wavelength	of	detection	 575	nm	 575	nm	
Range	of	linearity	 5‐200	μg/mL	 0.25‐8	μg/mL	
Regression	equation		 Area×10‐3	=	0.6710	C	(μg/mL)‐	0.2104		 Area	×	10‐4	=	2.7479	C	(μg/mL)	+	0.0155	
Regression	coefficient	(r2)	 1.0	 0.9998
LOD	 1.04	μg/mL 0.05	μg/mL
LOQ	 3.48	μg/mL 0.16	μg/mL
Sb	 1.39	×	10‐3 6.3×10‐2
Sa	 0.19 0.29
Confidence	limit	of	the	slope	 0.6710±0.13 2.7479±0.80
Confidence	limit	of	the	intercept	 ‐0.2104±0.29×10‐3 0.0155±0.10×10‐2	
Standard	error	of	the	estimation	 0.24	 0.4165	
Precision	 	
Intra‐day	%R.S.D.	 0.12‐0.58 0.24‐0.61
Inter‐day	%R.S.D.	 0.83‐1.53 0.72‐1.21
Drug	in	dosage	form	 100.39±1.43
Accuracy	 		
Drug	in	laboratory	prepared	mixture	 99.65±1.0 100.81±1.65
Drug	added	 99.62±1.56
*	%R.S.D.:	Percent	relative	standard	deviation,	LOD:	Limit	of	detection,	LOQ:	Limit	of	quantification.	
	
	
It	was	 found	 that	 85%	of	 organic	modifier	was	needed	 to	
elute	all	peaks	within	10	min.	Acetonitrile	was	found	optimum	
for	the	elution.	Besides,	different	buffers	at	different	pH	values	
were	 attempted	 along	 with	 acetonitrile.	 Therefore,	 a	 mobile	
phase	 consisting	 of	 potassium	 dihydrogen	 phosphate	 buffer	
(pH	=	4.6)	‐	acetonitrile	(15:85,	v:v)	and	pumped	at	a	flow	rate	
of	 1.0	mL/min,	 in	 an	 isocratic	mode,	 gave	 good	 separation	 of	
the	 three	compounds.	Detection	was	carried	out	at	220	nm	to	
obtain	 sufficient	 peak	 intensity	 for	 both	 drugs	 and	 SDG.	 The	
retention	 times	 were	 3.0,	 5.6	 and	 6.5	 min	 for	 SDP,	 STG	 and	
MET,	respectively	as	in	Figures	5	and	6.	
	
	
	
Figure	2.	 A	 typical	 LC	 chromatogram	with	 fluorometric	detection	 of	 25	µL	
injector	of	synthetic	binary	mixture	of	sitagliptin	acidic	degradation	product	
(30	µg/mL)	(a)	and	sitagliptin	(100	µg/mL)	(b).	
	
	
	
Figure	3.	 A	 typical	 LC	 chromatogram	with	 fluorometric	detection	 of	 25	µL	
injector	of	synthetic	binary	mixture	of	sitagliptin	acidic	degradation	product	
(1.5	µg/mL)	(a)	and	sitagliptin	(5	µg/mL)	(b)	in	plasma.	
	
3.1.3.	System	suitability	tests	
	
System	 suitability	 tests	 are	 used	 to	 verify	 that	 the	
resolution	 and	 reproducibility	were	 adequate	 for	 the	 analysis	
performed.	The	parameters	of	these	tests	are	column	efficiency	
(number	of	theoretical	plates),	tailing	of	chromatographic	peak,	
peak	 resolution	 factor,	 and	 repeatability	 as	 %R.S.D.	 of	 peak	
area	 for	 six	 injections	 and	 reproducibility	 of	 retention	 as	
%R.S.D.	of	retention	time.	The	results	of	these	tests	for	the	two	
proposed	methods	are	listed	in	Tables	1	and	2.		
	
	
Figure	4.	 A	 typical	 LC	 chromatogram	with	 fluorometric	 detection	 of	25	µL	
injector	of	Januvia®	sample	solution	(30	µg/mL).	
	
	
	
Figure	5. A	typical	LC	chromatogram	of	25	µL	 injector	of	synthetic	 ternary	
mixture	of	sitagliptin	acidic	degradation	product	(7.7	µg/mL)	(a),	sitagliptin	
(25.7	µg/mL)	(b),	and	metformin	(400	µg/mL)	(c).	
	
3.2.	Methods	validation	
	
3.2.1.	Linearity		
	
3.2.1.1.	LC‐fluoro	method	
	
A	 linear	 relationship	 between	 area	 under	 the	 peak	 (AUP)	
and	 STG	 concentration	 (C)	 was	 obtained.	 The	 regression	
equation	 was	 computed,	 Table	 3.	 The	 linearity	 of	 the	
calibration	curve	was	validated	by	the	high	value	of	correlation	
coefficient.		
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Table	4.	Results	obtained	by	LC‐UV	method	 for	 the	simultaneous	determination	of	sitagliptin	and	metformin	 in	the	presence	of	sitagliptin	acidic	degradation	
product.	
Item	*	 Sitagliptin Metformin
Retention	time	 5.6	 6.5
Wavelength	of	detection		 220	nm	 220	nm	
Range	of	linearity	 5‐160	μg/mL	 25‐800	μg/mL	
Regression	equation		 Area	×	10‐5	=	0.1285	C	(μg/mL)	‐	0.0098		 Area	×	10‐6	=	0.1191	C	(μg/mL)	+	0.6991		
Regression	coefficient	(r2)	 1.0	 0.9999	
LOD	 1.39	μg/mL 5.78	μg/mL
LOQ	 4.63	μg/mL 19.26	μg/mL
Sb	 4.48×10‐4 5.9×10‐4
Sa	 0.04	 0.27
Confidence	limit	of	the	slope	 0.1285±5.14×10‐3 0.1191±3.2×10‐2
Confidence	limit	of	the	intercept	 ‐0.0098	±0.04×10‐4 0.6991±4.12×10‐4	
Standard	error	of	the	estimation	 0.0035 0.39
Precision	 	
Intra‐day	%R.S.D.	 0.14‐0.47 0.08‐0.57
Inter‐day	%R.S.D.	 0.21‐1.35 0.24‐1.13
Drug	in	dosage	form	 100.24±1.63 100.55±1.31
Accuracy	 	
Drug	in	laboratory	mixture		 	99.72±1.50 99.70±1.74
Drug	added	 100.50±1.61 100.13±1.63
*	%R.S.D.:	Percent	relative	standard	deviation,	LOD:	Limit	of	detection,	LOQ:	Limit	of	quantification.	
	
	
	
	
Figure	6.	A	typical	LC	chromatogram	of	25	µL	 injector	of	 Janumet® sample	
solution,	sitagliptin	(25.7	µg/mL)	(a)	and	metformin	(400	µg/mL)	(b).
	
The	 analytical	 data	 of	 the	 calibration	 curve	 including	
standard	 deviations	 for	 the	 slope	 and	 intercept	 (Sb,	 Sa)	 are	
summarized	in	Table	3.	
	
3.2.1.2.	LC‐UV	method	
	
Linearity	 was	 studied	 for	 STG	 and	 MET.	 A	 linear	
relationship	 between	 area	 under	 the	 peak	 (AUP)	 and	
components’	 concentrations	 (C)	was	obtained.	The	 regression	
equation	 for	 each	 drug	 was	 also	 computed,	 Table	 4.	 The	
linearity	 of	 the	 calibration	 curves	were	 validated	 by	 the	 high	
value	 of	 correlation	 coefficients.	 The	 analytical	 data	 of	 the	
calibration	 curves	 including	 standard	 deviations	 for	 the	 slope	
and	intercept	(Sb,	Sa)	are	summarized	in	Table	4.		
	
3.2.2.	Accuracy	
	
3.2.2.1.	LC‐fluoro	method		
	
Accuracy	of	 the	results	was	calculated	by	%	recovery	of	5	
different	 concentrations	 of	 STG	 in	 laboratory‐prepared	
mixtures	 with	 SDP	 (10	 to	 30%	 of	 STG,	 w:w)	 and	 also	 by	
standard	 addition	 technique	 applied	 for	 Januvia®	 tablets,	 all	
carried	 out	 in	 triplicates.	 The	 results	 obtained	 including	 the	
mean	of	 the	 recovery	and	standard	deviation	are	displayed	 in	
Table	3.		
	
3.2.2.2.	LC‐UV	method		
	
Accuracy	of	the	results	was	calculated	by	%Recovery	of	five	
different	concentrations	of	the	laboratory	prepared	mixtures	of	
the	 two	 drugs	 with	 SDP	 and	 also	 by	 standard	 addition	
technique	 applied	 for	 Janumet®	 tablets,	 all	 carried	 out	 in	
triplicates.	 The	 results	 obtained	 including	 the	 mean	 of	 the	
recovery	and	standard	deviation	are	displayed	in	Table	4.	
	
3.2.3.	Precision		
	
3.2.3.1.	LC‐fluoro	method	
	
Precision	was	estimated	by	repeatability.	The	repeatability	
was	 assessed	 by	 analyzing	 a	 mixture	 containing	 30	 and	 100	
µg/mL	 of	 SPD	 and	 STG,	 respectively	 (n	 =	 6).	 The	 values	 of	
repeatability,	 intra‐day	 and	 inter‐day	 precision	 (using	 3	
different	 concentrations	 in	 triplicates	 for	 three	
consecutive	days)	for	STG	are	displayed	in	Tables	1	and	3.		
	
3.2.3.2.	LC‐UV	method	
	
The	 repeatability	 was	 assessed	 by	 analyzing	 a	 mixture	
containing	 25.7,	 400.0	 and	 7.7	 µg/mL	 of	 STG,	 MET	 and	 SDP,	
respectively	 (n	 =	 6).	 The	 values	 of	 repeatability	 for	 STG	 and	
MET	peaks,	intra‐day	and	inter‐day	precision	(using	3	different	
concentrations	 in	 triplicates	 for	 three	 consecutive	days)	 are	
displayed,	Tables	2	and	4.	
	
3.2.4.	Specificity	
	
Specificity	is	the	ability	of	the	analytical	method	to	measure	
the	analyte	response	in	the	presence	of	interferences	including	
degradation	 products	 and	 related	 substances.	 The	 proposed	
methods	were	used	 for	 the	determination	of	STG	alone	or	 the	
mixture	 of	 STG	 and	 MET	 in	 the	 presence	 of	 SDP;	 the	 acid	
degradation	of	STG.	Besides,	the	chromatograms	of	the	samples	
were	 checked	 for	 the	 appearance	 of	 any	 extra	 peaks.	 No	
chromatographic	 interference	 from	 any	 of	 the	 excipients	was	
found	 at	 the	 retention	 times	 of	 the	 examined	 compounds.	 In	
addition,	 the	 chromatogram	 of	 each	 compound	 in	 the	 sample	
solution	was	found	identical	 to	the	chromatogram	received	by	
the	standard	solution	at	the	wavelengths	applied.	These	results	
demonstrate	 the	absence	of	 interference	 from	other	materials	
in	 the	pharmaceutical	 formulations	 and	 therefore	 confirm	 the	
specificity	of	the	two	proposed	methods.		
	
3.2.5.	Robustness		
	
3.2.5.1.	LC‐fluoro	method	
	
Robustness	 was	 performed	 by	 deliberately	 changing	 the	
chromatographic	conditions.		
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Table	5.	Statistical	comparison	between	the	results	of	proposed	methods	and	the	reference	method	for	the	determination	of	sitagliptin.	
Statistical	term	a	 Reference	method	b	 LC‐fluoro	 LC‐fluoro	plasma	 LC‐UV	
Mean 100.5	 99.65 100.81 99.72
±S.D.	 1.39	 1.00 1.65 1.50
±S.E.	 0.62 0.45 0.74 0.67
%R.S.D.	 1.38	 1.00 1.64 1.50
n	 5	 5	 5	 5	
V	 1.93	 1.00	 2.72	 2.25	
t	(2.306)	c ‐ 1.10 0.32 0.85
a	S.D.:	Standard	deviation,	S.E.:	Standard	error,	%R.S.D.:	Relative	standard	deviation,	n:	Number	of	samples,	V:	Variance.	
b	 Reference	method:	 Aliquots	 of	 standard	 solutions	 in	 distilled	water	 containing	2‐10	μg/mL	 STG	were	measured	 at	 220	 nm	using	water	 as	 a	 blank	 [1].	No	
significant	difference	between	groups	by	using	one	way	ANOVA	with	F	=	0.84	and	p	=	0.49.	
c	Figure	in	parentheses	are	the	theoretical	t	value	at	(p	=	0.05).	
	
	
Table	6.	Statistical	comparison	between	the	proposed	method	and	the	reference	method	for	the	determination	of	metformin.	
Statistical	term	a		 Reference	Method	b HPLC	method		
Mean 100.4	 99.70
±S.D.	 0.28	 1.74
±S.E.	 0.13 0.78
%R.S.D.	 0.28	 1.75
n	 5	 5
V	 0.08	 3.03	
t	(2.306)	c ‐	 0.89	
a	S.D.:	Standard	deviation,	S.E.:	Standard	error,	%R.S.D.:	Relative	standard	deviation,	n:	Number	of	samples,	V:	Variance.	
b	Reference	method:	Aliquots	of	 standard	solutions	 in	distilled	water	containing	2‐12	μg/mL	MET	were	measured	at	232	nm	using	water	as	a	blank	[12].	No	
significant	difference	between	groups	by	using	one	way	ANOVA	with	F	=	0.79	and	p	=	0.4.	
c	Figure	in	parentheses	are	the	theoretical	t	value	at	(p	=	0.05).	
	
	
The	 most	 important	 parameter	 to	 be	 studied	 was	 the	
resolution	 factor	between	 the	 two	peaks	of	SDP	and	STG.	The	
flow	rate	of	 the	mobile	phase	was	changed	from	1	mL/min	 to	
0.8	mL/min	and	1.2	mL/min,	where	resolution	factors	obtained	
were	6.29,	6.14	and	6.08,	respectively.	The	ratio	of	acetonitrile	
was	 changed	 from	 70%	 to	 72%	 and	 68%,	 where	 resolution	
factors	obtained	were	6.29,	6.34	and	6.07,	respectively.	Finally,	
the	value	of	pH	of	the	phosphate	buffer	was	varied	from	4.6	to	
4.5	and	4.7,	where	resolution	factors	obtained	were	6.29,	6.39	
and	6.48,	respectively.	As	can	be	seen	from	these	results,	good	
values	 of	 the	 resolution	 factor	 were	 obtained	 for	 all	 these	
variations,	 indicating	 good	 robustness	 of	 the	 proposed	 LC	
method.	
	
3.2.5.2.	LC‐UV	method	
	
The	 most	 important	 parameter	 to	 be	 studied	 was	 the	
resolution	 factor	 between	 the	 two	peaks	 of	 SDP	 and	 STG	 and	
also	between	the	two	peaks	of	STG	and	MET.	The	flow	rate	of	
the	mobile	phase	was	changed	from	1	mL/min	to	0.8	mL/min	
and	1.2	mL/min,	where	 resolution	 factors	obtained	were	(6.5,	
2.1),	 (6.36,	 2.14)	 and	 (6.44,	 1.95),	 respectively.	 The	 ratio	 of	
acetonitrile	 was	 changed	 from	 85%	 to	 87%	 and	 83%,	 where	
resolution	 factors	obtained	were	 (6.5,	 2.1),	 (5.98,	1.89),	 (6.66,	
1.91),	 respectively.	 Finally,	 the	 value	 of	 pH	 of	 the	 phosphate	
buffer	 was	 varied	 from	 4.6	 to	 4.5	 and	 4.7,	 where	 resolution	
factors	 obtained	were	 (6.5,	 2.1),	 (6.33,	 2.12)	 and	 (6.18,	 2.16),	
respectively.	As	can	be	seen	from	these	results,	good	values	of	
the	 resolution	 factor	 were	 obtained	 for	 all	 these	 variations,	
indicating	good	robustness	of	the	proposed	LC	method.		
	
3.2.6.	Limit	of	detection	and	limit	of	quantification	
	
Limit	 of	 detection	 (LOD)	 which	 represents	 the	
concentration	 of	 analyte	 at	 S/N	 ratio	 of	 3	 and	 limit	 of	
quantification	 (LOQ)	 at	 which	 S/N	 is	 10	 were	 determined	
experimentally	for	the	proposed	methods	and	results	are	given	
in	Tables	3	and	4.		
	
3.2.7.	Statistical	analysis	
	
A	 statistical	 analysis	 of	 the	 results	 obtained	 by	 the	
proposed	methods	and	the	reference	methods	was	carried	out	
by	 “SPSS	 statistical	 package	 version	 11”.	 The	 significant	
difference	between	groups	was	 tested	by	one	way	ANOVA	(F‐
test)	 at	 p	 =	 0.05	 as	 shown	 in	 Tables	 5	 and	 6.	 The	 test	
ascertained	that	there	was	no	significant	difference	among	the	
methods.		
	
4.	Conclusion	
	
The	 two	 proposed	 LC	 methods	 proved	 to	 be	 simple,	
accurate	and	reproducible	for	the	determination	of	STG	either	
alone	or	in	combination	with	MET	in	the	presence	of	STG	acidic	
degradation	product	in	reasonable	run	times.	The	two	methods	
were	 validated	 showing	 satisfactory	 data	 for	 all	 the	 method	
validation	 parameters	 tested.	 The	 developed	 methods	 are	
stability	 indicating	 and	 can	 be	 conveniently	 used	 by	 quality	
control	laboratories.	
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